Petro Anastasia, Schwartz Jennifer, Johnson Timothy
Department of Dermatology, University of Michigan Health System and Comprehensive Cancer Center, Ann Arbor, Michigan, USA.
Clin Dermatol. 2004 May-Jun;22(3):223-7. doi: 10.1016/j.clindermatol.2003.12.010.
American Joint Committee on Cancer (AJCC), TNM staging, represents the cornerstone of management for cutaneous melanoma. This staging system groups patients with similar prognoses and has important implications in optimizing management and treatment and conducting better clinical trials. T describes the extent of the primary tumor, N the extent of regional lymph node metastases, and M the extent of distant metastases. The AJCC staging system for cutaneous melanoma underwent significant revision in 2002. The revised, current AJCC staging system and the TNM classification are detailed in this review.
美国癌症联合委员会(AJCC)的TNM分期是皮肤黑色素瘤管理的基石。该分期系统将预后相似的患者归为一组,对优化管理、治疗以及开展更好的临床试验具有重要意义。T代表原发肿瘤的范围,N代表区域淋巴结转移的范围,M代表远处转移的范围。2002年,AJCC皮肤黑色素瘤分期系统进行了重大修订。本综述详细介绍了修订后的现行AJCC分期系统及TNM分类。